[1]
T. Ciszewski, T. Kubiatowski, J. Szumiło, E. Starosławska, K. J. Czarnocki, and F. Burdan, “May peripheral blood hemoglobin concentration be a prognostic factor among patients diagnosed with metastatic clear cell renal carcinoma treated with targeted therapies?”, Curr. Issues Pharm. Med. Sci., vol. 24, no. 4, pp. 105–114, Oct. 2012, doi: 10.12923/.